Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-08-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.987025/full |
| ISSN: | 2297-055X |
|---|